A New Way To "Inflation Proof" Your Wealth

From The Gold Letter | Ad

When inflation hits an all time high, most investors see gold as a safe haven. However, this unusual investment is seeing 2:1 returns compared to gold. (While still giving you the protection that gold offers)

Click Here To See What It Is

ORIC Insider Trading (ORIC Pharmaceuticals)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: N/A

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $9,303,197.65

ORIC Pharmaceuticals Insider Trading History Chart

ORIC Pharmaceuticals Share Price & Price History

^$17.82

▲ +0.76 (4.45%)

As of 07/28/2021 04:20 PM ET

Days: 30 | 90 | 365

Three Cryptocurrencies to Hold in 2021

From Investorplace Media | Ad

In 2021, Dogecoin went up over 12,000%. SafeMoon went up more than 20,000%...

But if you missed those gains, there is still time to get in on the digital currency boom.

Luke Lango – InvestorPlace’s resident crypto expert – just released the names of 3 tokens every investor should own in a free report.

Click here to claim your copy today.

ORIC Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/24/2021	Jacob Chacko	CEO	Sell	12	$25.00	$300.00	27,934
5/24/2021	Richard A Heyman	Director	Sell	100	$25.00	$2,500.00	12,500
5/20/2021	Jacob Chacko	CEO	Sell	2,468	$25.07	$61,872.76	27,934
5/20/2021	Richard A Heyman	Director	Sell	700	$25.08	$17,556.00	12,500
5/17/2021	Richard A Heyman	Director	Sell	498	$25.07	$12,484.86	12,500
5/13/2021	Jacob Chacko	CEO	Sell	730	$25.04	$18,279.20	59,310
5/13/2021	Richard H Scheller	Director	Sell	100	$25.00	$2,500.00	49,200
5/11/2021	Jacob Chacko	CEO	Sell	1,090	$25.22	$27,489.80	59,310
5/11/2021	Richard A Heyman	Director	Sell	100	$25.11	$2,511.00	49,200
4/30/2021	Jacob Chacko	CEO	Sell	1,300	$25.14	$32,682.00	61,000
4/30/2021	Richard A Heyman	Director	Sell	100	$25.26	$2,526.00	12,500
4/28/2021	Jacob Chacko	CEO	Sell	700	$25.06	$17,542.00	61,000
4/28/2021	Richard A Heyman	Director	Sell	100	$25.08	$2,508.00	12,500
4/1/2021	Jacob Chacko	CEO	Sell	800	$25.09	$20,072.00	61,700
4/1/2021	Richard H Scheller	Director	Sell	200	$25.00	$5,000.00	49,800
3/29/2021	Carl L Gordon	Director	Sell	75,555	$23.31	$1,761,187.05
3/26/2021	Orbimed Advisors Llc	Director	Sell	27,816	$23.88	$664,246.08
3/24/2021	Orbimed Advisors Llc	Director	Sell	32,959	$24.80	$817,383.20
3/22/2021	Carl L Gordon	Director	Sell	7,673	$26.47	$203,104.31
3/19/2021	Carl L Gordon	Director	Sell	21,275	$26.47	$563,149.25
3/17/2021	Orbimed Advisors Llc	Director	Sell	18,790	$28.43	$534,199.70
3/15/2021	Orbimed Advisors Llc	Director	Sell	89,210	$29.14	$2,599,579.40
3/11/2021	Orbimed Advisors Llc	Director	Sell	58,551	$33.04	$1,934,525.04
4/24/2020	Orbimed Advisors Llc	Director	Buy	281,250	$25.68	$7,222,500.00

Insider Trading at ORIC Pharmaceuticals?

Sign-up to receive InsiderTrades.com's daily insider buying and selling report for ORIC Pharmaceuticals and related companies.

SEC Filings (Institutional Ownership Changes) for ORIC Pharmaceuticals (NASDAQ:ORIC)

97.25% of ORIC Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

ORIC Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/19/2021	Squarepoint Ops LLC	10,342	$0.25M	0.0%	N/A	0.028%
5/18/2021	Millennium Management LLC	123,457	$3.03M	0.0%	+21.2%	0.336%
5/18/2021	Point72 Asset Management L.P.	1,285,647	$31.50M	0.1%	N/A	3.504%
5/18/2021	D. E. Shaw & Co. Inc.	9,812	$0.24M	0.0%	N/A	0.027%
5/18/2021	Morgan Stanley	12,885	$0.32M	0.0%	-58.7%	0.035%
5/18/2021	Orbimed Advisors LLC	2,337,574	$57.27M	0.5%	-20.0%	6.370%
5/18/2021	Alyeska Investment Group L.P.	285,445	$6.99M	0.1%	+14.7%	0.778%
5/18/2021	Cubist Systematic Strategies LLC	1,350	$33K	0.0%	N/A	0.004%
5/18/2021	Euclidean Capital LLC	996,734	$24.42M	8.2%	-28.8%	2.716%
5/18/2021	California State Teachers Retirement System	34,089	$0.84M	0.0%	+1.6%	0.093%
5/17/2021	Great West Life Assurance Co. Can	1,440	$35K	0.0%	+133.8%	0.004%
5/17/2021	Royal Bank of Canada	1,991	$49K	0.0%	+291.2%	0.005%
5/17/2021	HRT Financial LP	49,514	$1.21M	0.0%	N/A	0.135%
5/17/2021	Nuveen Asset Management LLC	73,198	$1.79M	0.0%	+7.7%	0.199%
5/17/2021	Sphera Funds Management LTD.	169,900	$4.16M	0.3%	-6.8%	0.463%
5/17/2021	Goldman Sachs Group Inc.	26,320	$0.65M	0.0%	+47.7%	0.072%
5/14/2021	Laurion Capital Management LP	77,000	$1.89M	0.0%	-20.2%	0.210%
5/14/2021	C M Bidwell & Associates Ltd.	6,755	$0.17M	0.1%	N/A	0.018%
5/14/2021	UBS Asset Management Americas Inc.	11,000	$0.27M	0.0%	+48.6%	0.030%
5/13/2021	SG Americas Securities LLC	5,695	$0.14M	0.0%	N/A	0.016%
5/13/2021	Bank of New York Mellon Corp	76,787	$1.88M	0.0%	+4.1%	0.209%
5/12/2021	Northern Trust Corp	230,757	$5.65M	0.0%	-2.7%	0.629%
5/12/2021	Geode Capital Management LLC	336,463	$8.24M	0.0%	+7.0%	0.917%
5/12/2021	JPMorgan Chase & Co.	11,674	$0.29M	0.0%	+17.3%	0.032%
5/12/2021	E Fund Management Co. Ltd.	2,803	$69K	0.0%	N/A	0.008%
5/12/2021	UBS Group AG	31,504	$0.77M	0.0%	+1,963.1%	0.086%
5/11/2021	New York State Common Retirement Fund	21,500	$0.53M	0.0%	+16.8%	0.059%
5/11/2021	Jennison Associates LLC	1,143,479	$28.02M	0.0%	+118.4%	3.116%
5/10/2021	Rafferty Asset Management LLC	67,364	$1.65M	0.0%	N/A	0.184%
5/7/2021	BlackRock Inc.	1,910,353	$46.80M	0.0%	+1.7%	5.206%
5/7/2021	Swiss National Bank	62,300	$1.53M	0.0%	+53.4%	0.170%
5/6/2021	Rhumbline Advisers	22,487	$0.55M	0.0%	+2.3%	0.061%
5/6/2021	Alliancebernstein L.P.	25,900	$0.64M	0.0%	+4.4%	0.071%
5/4/2021	Victory Capital Management Inc.	1,105,374	$27.08M	0.0%	+0.5%	3.012%
5/3/2021	Zurcher Kantonalbank Zurich Cantonalbank	1,649	$40K	0.0%	N/A	0.004%
4/29/2021	Emerald Mutual Fund Advisers Trust	624,210	$15.29M	0.5%	+27.9%	1.701%
4/29/2021	Emerald Advisers LLC	615,511	$15.08M	0.5%	+17.8%	1.677%
4/5/2021	Pacer Advisors Inc.	1,572	$39K	0.0%	N/A	0.004%
3/12/2021	DekaBank Deutsche Girozentrale	10,500	$0.41M	0.0%	N/A	0.034%
3/2/2021	Norges Bank	12,500	$0.42M	0.0%	N/A	0.041%
3/1/2021	UBS Asset Management Americas Inc.	7,400	$0.25M	0.0%	N/A	0.024%
2/24/2021	Alyeska Investment Group L.P.	248,898	$8.43M	0.1%	+54.0%	0.807%
2/19/2021	JPMorgan Chase & Co.	9,951	$0.34M	0.0%	+206.6%	0.032%
2/19/2021	International Biotechnology Trust PLC	53,000	$1.79M	0.5%	N/A	0.172%
2/16/2021	Alyeska Investment Group L.P.	248,898	$8.43M	0.1%	+54.0%	0.807%
2/16/2021	Nuveen Asset Management LLC	67,996	$2.30M	0.0%	+100.9%	0.220%
2/16/2021	Charles Schwab Investment Management Inc.	109,713	$3.71M	0.0%	+107.5%	0.356%
2/13/2021	American International Group Inc.	12,898	$0.44M	0.0%	+147.7%	0.042%
2/12/2021	Laurion Capital Management LP	96,536	$3.27M	0.0%	+25.4%	0.313%
2/12/2021	Penserra Capital Management LLC	840	$28K	0.0%	N/A	0.003%
2/12/2021	The Manufacturers Life Insurance Company	12,907	$0.44M	0.0%	N/A	0.042%
2/12/2021	Credit Suisse AG	21,322	$0.72M	0.0%	N/A	0.069%
2/12/2021	Virtus ETF Advisers LLC	8,247	$0.28M	0.1%	N/A	0.027%
2/12/2021	M&T Bank Corp	9,153	$0.31M	0.0%	+13.7%	0.030%
2/11/2021	Northern Trust Corp	237,047	$8.02M	0.0%	+123.8%	0.769%
2/11/2021	Citigroup Inc.	8,643	$0.29M	0.0%	+214.1%	0.028%
2/11/2021	Artal Group S.A.	100,000	$3.39M	0.1%	-29.8%	0.324%
2/11/2021	Asymmetry Capital Management L.P.	67,210	$2.28M	1.0%	N/A	0.218%
2/10/2021	Rhumbline Advisers	21,992	$0.74M	0.0%	+153.2%	0.071%
2/9/2021	Wells Fargo & Company MN	853,806	$28.90M	0.0%	+36.8%	2.769%
2/9/2021	Bank of New York Mellon Corp	73,731	$2.50M	0.0%	+226.5%	0.239%
2/9/2021	ProShare Advisors LLC	10,569	$0.36M	0.0%	N/A	0.034%
2/8/2021	Alliancebernstein L.P.	24,800	$0.84M	0.0%	+117.5%	0.080%
2/8/2021	Beacon Investment Advisory Services Inc.	17,556	$0.59M	0.0%	N/A	0.057%
2/8/2021	New York State Common Retirement Fund	18,400	$0.62M	0.0%	+130.0%	0.060%
2/6/2021	Jennison Associates LLC	523,480	$17.72M	0.0%	+247.6%	1.698%
2/5/2021	BlackRock Inc.	1,878,908	$63.60M	0.0%	+142.7%	6.093%
2/5/2021	Swiss National Bank	40,600	$1.37M	0.0%	N/A	0.132%
2/4/2021	State of Wisconsin Investment Board	12,400	$0.42M	0.0%	-10.8%	0.040%
2/1/2021	Victory Capital Management Inc.	1,100,293	$37.25M	0.0%	+22.6%	3.568%
1/29/2021	Emerald Mutual Fund Advisers Trust	488,234	$16.53M	0.6%	+56.2%	1.583%
1/29/2021	Emerald Advisers LLC	522,302	$17.68M	0.6%	+60.9%	1.694%
1/25/2021	Strs Ohio	5,400	$0.18M	0.0%	+145.5%	0.018%
11/16/2020	ArrowMark Colorado Holdings LLC	995,382	$24.90M	0.2%	+280.2%	3.228%
11/16/2020	Alkeon Capital Management LLC	303,061	$7.58M	0.0%	N/A	0.983%
11/13/2020	Charles Schwab Investment Management Inc.	52,876	$1.32M	0.0%	-1.6%	0.171%
11/12/2020	JPMorgan Chase & Co.	3,246	$75K	0.0%	-47.8%	0.011%
11/10/2020	State Street Corp	120,320	$3.01M	0.0%	+22.8%	0.402%
11/9/2020	SG Americas Securities LLC	91,997	$2.30M	0.0%	+309.3%	0.307%
11/9/2020	Victory Capital Management Inc.	897,134	$22.44M	0.0%	+57.9%	2.995%
11/6/2020	BlackRock Inc.	774,207	$19.36M	0.0%	-10.9%	2.584%
11/6/2020	M&T Bank Corp	8,047	$0.20M	0.0%	+28.4%	0.027%
11/5/2020	California Public Employees Retirement System	20,049	$0.50M	0.0%	+4.2%	0.067%
11/5/2020	Wells Fargo & Company MN	623,936	$15.61M	0.0%	+9.3%	2.083%
11/4/2020	Jennison Associates LLC	150,601	$3.77M	0.0%	+0.4%	0.503%
11/4/2020	Raymond James & Associates	36,226	$0.91M	0.0%	+19.6%	0.121%
10/28/2020	Emerald Advisers LLC	324,582	$8.12M	0.3%	+74.4%	1.084%
10/28/2020	Emerald Mutual Fund Advisers Trust	312,483	$7.82M	0.3%	+84.7%	1.043%
8/25/2020	Nuveen Asset Management LLC	33,693	$1.14M	0.0%	N/A	0.112%
8/24/2020	FMR LLC	4,206,948	$138.79M	0.0%	N/A	14.042%
8/24/2020	ArrowMark Colorado Holdings LLC	261,778	$8.83M	0.1%	N/A	0.874%
8/20/2020	Charles Schwab Investment Management Inc.	53,722	$1.81M	0.0%	N/A	0.179%
8/18/2020	Blackstone Group Inc	5,500	$0.19M	0.0%	N/A	0.018%
8/17/2020	Jane Street Group LLC	19,161	$0.65M	0.0%	N/A	0.064%
8/14/2020	Orbimed Advisors LLC	2,921,967	$98.56M	1.4%	N/A	9.754%
8/14/2020	Deerfield Management Company L.P. Series C	300,000	$10.12M	0.3%	N/A	1.001%
8/14/2020	Bank of America Corp DE	13,360	$0.45M	0.0%	N/A	0.045%
8/14/2020	Artal Group S.A.	150,000	$5.06M	0.1%	N/A	0.501%
8/14/2020	Alyeska Investment Group L.P.	161,585	$5.45M	0.1%	N/A	0.539%
8/13/2020	Sofinnova Investments Inc.	17,369	$0.59M	0.0%	N/A	0.058%

Data available starting January 2016

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers. The company's lead product candidate is ORIC-101, a small molecule antagonist of the glucocorticoid receptor, which has been linked to resistance to multiple classes of cancer therapeutics across various solid tumors. Its other product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens; ORIC-944, an allosteric inhibitor for prostate cancer; and ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations. The company is also developing multiple precision medicines targeting other cancer resistance mechanisms. It has collaboration and license agreement with Astellas Pharma, Inc.; Voronoi, Inc.; and Mirati Therapeutics, Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.

Today's Range

Now: $17.82

$16.94

$17.93

50 Day Range

MA: $19.82

$16.69

$25.07

52 Week Range

Now: $17.82

$15.97

$40.81

Volume

2,478 shs

Average Volume

249,112 shs

Market Capitalization

$653.92 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.89

Who are the company insiders with the largest holdings of ORIC Pharmaceuticals?

ORIC Pharmaceuticals' top insider shareholders include:

Jacob Chacko (CEO)
Richard H Scheller (Director)
Richard A Heyman (Director)
Carl L Gordon (Director)
Orbimed Advisors Llc (Director)

A New Way To "Inflation Proof" Your Wealth

From The Gold Letter | Ad

Click Here To See What It Is